Related Experiment Video
Updated: Jan 19, 2026

Effects of Taste Signaling Protein Abolishment on Gut Inflammation in an Inflammatory Bowel Disease Mouse Model
Published on: November 9, 2018
Inflammatory Ocular Diseases and Sphingolipid Signaling
Richard Grambergs1, Koushik Mondal1, Nawajes Mandal2,3
1Department of Ophthalmology, University of Tennessee Health Science Center, UTHSC, Memphis, TN, USA.
Inflammation, while vital for healing, can cause eye diseases when dysregulated. Sphingolipids are emerging as key mediators in ocular inflammation and blindness.
Area of Science:
- Immunology
- Ophthalmology
- Molecular Biology
Background:
- Inflammation is a critical immune response to injury and infection, involving complex signaling pathways.
- While essential for healing, dysregulated inflammation can lead to disease, including in the eye.
- Ocular inflammatory diseases are a significant cause of human blindness.
Purpose of the Study:
- To discuss fundamental inflammatory processes.
- To highlight the role of sphingolipids as mediators in inflammation.
- To review major inflammatory ocular diseases and sphingolipid involvement in their pathogenesis.
Main Methods:
- Literature review of inflammatory processes.
- Analysis of sphingolipid signaling in ocular inflammation.
- Discussion of current findings on sphingolipids in ocular disease pathogenesis.
Main Results:
- Inflammation, though protective, can become pathogenic when uncontrolled.
- Sphingolipids are increasingly recognized as crucial signaling molecules in inflammatory conditions.
- Evidence suggests sphingolipids play a significant role in the development of various ocular inflammatory diseases.
Conclusions:
- Understanding inflammation is key to addressing ocular diseases.
- Sphingolipids represent a promising area of research for therapeutic interventions in ocular inflammation.
- Further investigation into sphingolipid pathways may uncover new treatments for blindness-causing eye conditions.
Related Concept Videos
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
09:31Effects of Taste Signaling Protein Abolishment on Gut Inflammation in an Inflammatory Bowel Disease Mouse Model
05:37Intravitreous Injection for Establishing Ocular Diseases Model
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
